Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma

NCT01241682 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT01241682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01241682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma
Lead sponsor
Erasmus Medical Center
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2009
Completion date
October 31, 2012
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant (pleural) mesothelioma